BG Medicine, Inc. (BGMD) - Product Pipeline Analysis

BG Medicine, Inc. (BGMD) - Product Pipeline Analysis

Summary

BG Medicine, Inc. (BGM) is a biotechnology and pharmaceutical company, based in the US. The company discovers, develops and commercializes novel molecular diagnostics tests. It operates through product segments such as Galectin-3 and pipeline. BGM Galectin-3 test for heart failure is a novel diagnostic test for measuring galectin-3 levels in blood plasma or serum. Its pipeline product includes Galectin-3, Galectin-3 Post-MI, AMIPredict, LipidDx, multiple sclerosis and Anti-TNF alpha drug response. The company develops pipeline of molecular diagnostics that are utilized to aid in the diagnosis and treatment of various diseases, including cardiovascular diseases, cancer and central nervous system disorders. BGM is headquartered in Waltham

This report is a source for data, analysis and actionable intelligence on the BG Medicine, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize. SHOW LESS READ MORE >

List of Tables
List of Figures
Key Facts
BG Medicine, Inc. - Major Products and Services
BG Medicine, Inc. Pipeline Products by Equipment Type
BG Medicine, Inc. Pipeline Products by Development Stage
BG Medicine, Inc. Pipeline Products by Therapy Area
BG Medicine, Inc. Pipeline Products by Milestone Summary
Automated BGM Galectin-3 Assay
Automated BGM Galectin-3 Assay Product Status
Automated BGM Galectin-3 Assay Product Description
Automated BGM Galectin-3 Assay Product Patent Details
BGM Galectin-3 - Heart Failure Treatment Decisions
BGM Galectin-3 - Heart Failure Treatment Decisions Product Status
BGM Galectin-3 - Heart Failure Treatment Decisions Product Description
Biomarkers - Enbrel Treatment
Biomarkers - Enbrel Treatment Product Status
Biomarkers - Enbrel Treatment Product Description
Biomarkers - Humira Treatment
Biomarkers - Humira Treatment Product Status
Biomarkers - Humira Treatment Product Description
Biomarkers - Remicade Treatment
Biomarkers - Remicade Treatment Product Status
Biomarkers - Remicade Treatment Product Description
CardioSCORE
CardioSCORE Product Status
CardioSCORE Product Description
CardioSCORE Product Milestone
Diagnostic Assay - Multiple Sclerosis
Diagnostic Assay - Multiple Sclerosis Product Status
Diagnostic Assay - Multiple Sclerosis Product Description
Diagnostic Assay - Multiple Sclerosis Product Milestone
Galectin-3 Test - Inverness Triage Meter Pro
Galectin-3 Test - Inverness Triage Meter Pro Product Status
Galectin-3 Test - Inverness Triage Meter Pro Product Description
Galectin-3 Test - Inverness Triage Meter Pro Product Milestone
Galectin-3 Test - Inverness Triage Meter Pro Product Patent Details
LipidDx
LipidDx Product Status
LipidDx Product Description
BG Medicine, Inc. - Key Competitors
BG Medicine, Inc. - Key Employees
BG Medicine, Inc. - Locations And Subsidiaries
Head Office
Recent Developments
BG Medicine, Inc., Recent Developments
May 15, 2012: BG Medicine Reports Q1 2012 Results
Mar 13, 2012: BG Medicine Announces Schedule Of Events Related To Galectin-3 And Heart Failure At American College Of Cardiology's 61st Annual Scientific Session & Expo
Mar 08, 2012: BG Medicine Reports Revenue Of $1.6m In 2011
Feb 13, 2012: BG Medicine Appoints Brian S Posner To Board Of Directors
Jan 09, 2012: BG Medicine Appoints Eric Bouvier As CEO
Nov 30, 2011: BG Medicine Announces Peer-Reviewed Publication On Galectin-3 And Development Of Heart Failure After Acute Coronary Syndrome
Jul 27, 2011: BG Medicine Appoints Stephane Bancel As Executive Chairman
Jul 18, 2011: BG Medicine Receives ISO 13485 Certification
Jun 28, 2011: BG Medicine Appoints Stephen R Miller As Chief Commercial Officer
Appendix
Methodology
About Us
Contact Us
Disclaimer

List of Tables
BG Medicine, Inc., Key Facts
BG Medicine, Inc. Key Pipeline Products by Equipment Type
BG Medicine, Inc. Key Pipeline Products by Therapy Area
BG Medicine, Inc. Key Pipeline Products by Development Stage
BG Medicine, Inc., Key Facts
BG Medicine, Inc., Major Products and Services
BG Medicine, Inc. Number of Pipeline Products by Equipment Type
BG Medicine, Inc. Pipeline Products by Equipment Type
BG Medicine, Inc. Number of Pipeline Products by Development Stage
BG Medicine, Inc. Pipeline Products by Development Stage
BG Medicine, Inc. Number of Pipeline Products by Therapy Area
BG Medicine, Inc. Pipeline Products by Therapy Area
BG Medicine, Inc. Number of Pipeline Products By Milestone Summary
BG Medicine, Inc. Pipeline Products by Milestone Summary
Automated BGM Galectin-3 Assay - Product Status
Automated BGM Galectin-3 Assay - Product Description
Automated BGM Galectin-3 Assay - Patent Details1
Automated BGM Galectin-3 Assay - Patent Details2
Automated BGM Galectin-3 Assay - Patent Details3
Automated BGM Galectin-3 Assay - Patent Details4
BGM Galectin-3 - Heart Failure Treatment Decisions - Product Status
BGM Galectin-3 - Heart Failure Treatment Decisions - Product Description
Biomarkers - Enbrel Treatment - Product Status
Biomarkers - Enbrel Treatment - Product Description
Biomarkers - Humira Treatment - Product Status
Biomarkers - Humira Treatment - Product Description
Biomarkers - Remicade Treatment - Product Status
Biomarkers - Remicade Treatment - Product Description
CardioSCORE - Product Status
CardioSCORE - Product Description
CardioSCORE - Product Milestone
Diagnostic Assay - Multiple Sclerosis - Product Status
Diagnostic Assay - Multiple Sclerosis - Product Description
Diagnostic Assay - Multiple Sclerosis - Product Milestone
Galectin-3 Test - Inverness Triage Meter Pro - Product Status
Galectin-3 Test - Inverness Triage Meter Pro - Product Description
Galectin-3 Test - Inverness Triage Meter Pro - Product Milestone
Galectin-3 Test - Inverness Triage Meter Pro - Patent Details1
Galectin-3 Test - Inverness Triage Meter Pro - Patent Details2
Galectin-3 Test - Inverness Triage Meter Pro - Patent Details3
Galectin-3 Test - Inverness Triage Meter Pro - Patent Details4
LipidDx - Product Status
LipidDx - Product Description
BG Medicine, Inc., Key Employees

List of Figures
BG Medicine, Inc. Key Pipeline Products by Equipment Type
BG Medicine, Inc. Pipeline Products by Equipment Type
BG Medicine, Inc. Pipeline Products by Development Stage
BG Medicine, Inc. Pipeline Products by Therapy Area
BG Medicine, Inc. Pipeline Products by Milestone Summary

Wescor, Inc
Immuno Concepts Inc
Haemoscope Corporation
Micronics, Inc.
CombiMatrix Corporation